[go: up one dir, main page]

GB201011411D0 - Therapeutic compounds and their use - Google Patents

Therapeutic compounds and their use

Info

Publication number
GB201011411D0
GB201011411D0 GBGB1011411.4A GB201011411A GB201011411D0 GB 201011411 D0 GB201011411 D0 GB 201011411D0 GB 201011411 A GB201011411 A GB 201011411A GB 201011411 D0 GB201011411 D0 GB 201011411D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1011411.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manchester
City St Georges University of London
Original Assignee
University of Manchester
St Georges Hospital Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manchester, St Georges Hospital Medical School filed Critical University of Manchester
Priority to GBGB1011411.4A priority Critical patent/GB201011411D0/en
Publication of GB201011411D0 publication Critical patent/GB201011411D0/en
Priority to PCT/GB2011/001011 priority patent/WO2012004554A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1011411.4A 2010-07-06 2010-07-06 Therapeutic compounds and their use Ceased GB201011411D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1011411.4A GB201011411D0 (en) 2010-07-06 2010-07-06 Therapeutic compounds and their use
PCT/GB2011/001011 WO2012004554A1 (en) 2010-07-06 2011-07-04 Aldehyde compounds as inhibitors of dust mite group 1 peptidase allergen and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1011411.4A GB201011411D0 (en) 2010-07-06 2010-07-06 Therapeutic compounds and their use

Publications (1)

Publication Number Publication Date
GB201011411D0 true GB201011411D0 (en) 2010-08-18

Family

ID=42669292

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1011411.4A Ceased GB201011411D0 (en) 2010-07-06 2010-07-06 Therapeutic compounds and their use

Country Status (2)

Country Link
GB (1) GB201011411D0 (en)
WO (1) WO2012004554A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201001070D0 (en) 2010-01-22 2010-03-10 St George's Hospital Medical School Theraputic compounds and their use
CN103655557B (en) * 2012-09-11 2018-03-30 北京大学 Purposes of the CD38 enzyme inhibitors in airway hyperreactivity disease is treated
US10829440B2 (en) 2015-06-12 2020-11-10 Brown University Antibacterial compounds and methods of making and using same
US10550070B2 (en) 2015-09-17 2020-02-04 City Of Hope PCNA inhibitors
US11555010B2 (en) 2019-07-25 2023-01-17 Brown University Diamide antimicrobial agents
JP7598325B2 (en) 2019-09-25 2024-12-11 日産化学株式会社 Method for producing peptide compounds
WO2024028417A1 (en) 2022-08-03 2024-02-08 Institut National de la Santé et de la Recherche Médicale New composition for the treatment and/or prevention of vitiligo

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1011411A (en) 1960-11-13 1965-12-01 B C M Plastic Developments Ltd Improvements in the production of tube bends of reinforced thermo-setting plastic
EP0100673A2 (en) 1982-08-02 1984-02-15 The Research Foundation Of State University Of New York A method of enhancing neurofiber regrowth
DE4331135A1 (en) 1993-09-14 1995-03-16 Bayer Ag New antiviral valine-containing pseudopeptides
US5580854A (en) 1994-03-04 1996-12-03 Mount Sinai School Of Medicine Of The City University Of New York Substrate-related peptidyl-aldehyde inhibitors of the proteolytic activity of the multicatalytic proteinase complex
WO1996030395A2 (en) 1995-03-31 1996-10-03 Takeda Chemical Industries, Ltd. Cysteine protease inhibitor
DE69633623T2 (en) * 1995-07-17 2005-12-01 Medivir Uk Ltd. Cysteine protease inhibitors for the treatment of allergic diseases caused by IgE
AU1599497A (en) 1996-02-16 1997-09-02 Bayer Aktiengesellschaft Oxime- and nitron-substituted pseudopeptides with an anti-viral action
RU2274642C2 (en) 1998-03-19 2006-04-20 Вертекс Фармасьютикалз Инкорпорейтед Caspase inhibitors
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs

Also Published As

Publication number Publication date
WO2012004554A1 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
EP2542086A4 (en) Compounds and therapeutic uses thereof
IL249669A0 (en) Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
GB201004020D0 (en) New therapeutic use
SG10201506840QA (en) Cytotoxicity-inducing therapeutic agent
EP2739144A4 (en) Compounds and therapeutic uses thereof
IL221511A (en) Bisaryl-linked aryltriazolones and their use
GB201010193D0 (en) Medicinal use
ZA201208173B (en) Peptices and their use
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
ZA201303773B (en) Compounds and their use
ZA201304012B (en) Novel compound and medical use thereof
GB201011411D0 (en) Therapeutic compounds and their use
GB0913300D0 (en) Therapeutic compounds and their use
GB201005511D0 (en) Compounds and their use
GB201018028D0 (en) Compounds and their use
GB201000308D0 (en) Compounds and their use
GB201000309D0 (en) Compounds and their use
GB201002337D0 (en) Compounds and their use
GB201017822D0 (en) Compounds and their use
GB201000305D0 (en) Compounds and their use
GB201020848D0 (en) Compounds and their use
GB201000307D0 (en) Compounds and their use
GB201021708D0 (en) Novel Therapeutic use
GB201001376D0 (en) New compounds and medical uses
GB201001364D0 (en) New compounds and medical uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)